论文介绍
脂肪代谢
学术信息和材料按类型划分。请点击您想要浏览的内容。
 
癌症、免疫 血糖 血压 肝脏 脂肪代谢
         
镇痛 抗衰老、美容 过敏 炎症  
         

Ganoderma lucidum mushroom for the treatment of cardiovascular risk factors.
Klupp NL, Chang D, Hawke F, Kiat H, Cao H, Grant SJ, Bensoussan A.
Cochrane Database Syst Rev. 2015 Feb 17;2:CD007259. doi: 10.1002/14651858.CD007259.pub2.

Development of liposomal Ganoderma lucidum polysaccharide: formulation optimization and evaluation of its immunological activity.
Liu Z, Ma X, Deng B, Huang Y, Bo R, Gao Z, Yu Y, Hu Y, Liu J, Wu Y, Wang D.
Carbohydr Polym. 2015 Mar 6;117:510-7. doi: 10.1016/j.carbpol.2014.09.093. Epub 2014 Oct 15.

Exopolysaccharide from Ganoderma applanatum as a promising bioactive compound with cytostatic and antibacterial properties.
Osińska-Jaroszuk M, Jaszek M, Mizerska-Dudka M, B?achowicz A, Rejczak TP, Janusz G, Wydrych J, Polak J, Jarosz-Wilko?azka A, Kandefer-Szerszeń M.
Biomed Res Int. 2014;2014:743812. doi: 10.1155/2014/743812. Epub 2014 Jul 10.

Evaluation of a crataegus-based multiherb formula for dyslipidemia: a randomized, double-blind, placebo-controlled clinical trial.
Hu M, Zeng W, Tomlinson B.
Evid Based Complement Alternat Med. 2014;2014:365742. doi: 10.1155/2014/365742. Epub 2014 Apr 16.

HPLC analysis of Ganoderma lucidum polysaccharides and its effect on antioxidant enzymes activity and Bax, Bcl-2 expression.
Yang Q, Wang S, Xie Y, Sun J, Wang J.
Int J Biol Macromol. 2010 Mar 1;46(2):167-72.

Novel hypoglycemic effects of Ganoderma lucidum water-extract in obese/diabetic (+db/+db) mice.
Seto SW, Lam TY, Tam HL, Au AL, Chan SW, Wu JH, Yu PH, Leung GP, Ngai SM, Yeung JH, Leung PS, Lee SM, Kwan YW.
Phytomedicine. 2009 May;16(5):426-36.

Prevention of cisplatin induced nephrotoxicity by terpenes isolated from Ganoderma lucidum occurring in Southern Parts of India.
Pillai TG, John M, Sara Thomas G.
Exp Toxicol Pathol. 2009 Dec 2.

Hypoglycemic effects of Ganoderma applanatum and Collybia confluens exo-polymers in streptozotocin-induced diabetic rats.
Yang BK, Jung YS, Song CH.
Phytother Res. 2007 Nov;21(11):1066-9. 

Effects of Ganoderma lucidum polysaccharide on CYP2E1, CYP1A2 and CYP3A activities in BCG-immune hepatic injury in rats.
Wang X, Zhao X, Li D, Lou YQ, Lin ZB, Zhang GL.
Biol Pharm Bull. 2007 Sep;30(9):1702-6.

Secondary metabolites from Ganoderma lucidum and Spongiporus leucomallellus.
Campos Ziegenbein F, Hanssen HP, König WA.
Phytochemistry. 2006 Jan;67(2):202-11.

Effect of polysaccharides from Ganoderma lucidum on streptozotocin-induced diabetic nephropathy in mice.
He CY, Li WD, Guo SX, Lin SQ, Lin ZB.
J Asian Nat Prod Res. 2006 Dec;8(8):705-11.

Ganoderma tsugae in vivo modulates Th1/Th2 and macrophage responses in an allergic murine model.
Lin JY, Chen ML, Lin BF.
Food Chem Toxicol. 2006 Dec;44(12):2025-32.

Antimutagenic activity of methanolic extract of Ganoderma lucidum and its effect on hepatic damage caused by benzo[a]pyrene.
Lakshmi B, Ajith TA, Jose N, Janardhanan KK.
J Ethnopharmacol. 2006 Sep 19;107(2):297-303.

Effect of 26-oxygenosterols from Ganoderma lucidum and their activity as cholesterol synthesis inhibitors.
Hajjaj H, Macé C, Roberts M, Niederberger P, Fay LB.
Appl Environ Microbiol. 2005 Jul;71(7):3653-8. 

[Effects of ganoderma lucidum polysaccharides on serum lipids and lipoperoxidation in experimental hyperlipidemic rats]
Chen WQ, Luo SH, Ll HZ, Yang H.
Zhongguo Zhong Yao Za Zhi. 2005 Sep;30(17):1358-60.

Cellular and physiological effects of Ganoderma lucidum (Reishi).
Sliva D.
Mini Rev Med Chem. 2004 Oct;4(8):873-9.

Cholesterol-lowering properties of Ganoderma lucidum in vitro, ex vivo, and in hamsters and minipigs.
Berger A, Rein D, Kratky E, Monnard I, Hajjaj H, Meirim I, Piguet-Welsch C, Hauser J, Mace K, Niederberger P.
Lipids Health Dis. 2004 Feb 18;3:2.

In vitro and in vivo protective effect of Ganoderma lucidum polysaccharides on alloxan-induced pancreatic islets damage.
Zhang HN, He JH, Yuan L, Lin ZB.
Life Sci. 2003 Sep 19;73(18):2307-19.

[Antioxidant effect of Ganoderma polysaccharide peptide]
You YH, Lin ZB.
Yao Xue Xue Bao. 2003 Feb;38(2):85-8.

Natural products of the medicinal fungus Ganoderma lucidum: occurrence, biological activities, and pharmacological functions.
Shiao MS.
Chem Rec. 2003;3(3):172-80.

[Advances of pharmacological effects of triterpenes from Ganoderma lucidum]
Luo J, Lin ZB.
Yao Xue Xue Bao. 2002 Jul;37(7):574-8.

[Effect of lugu Ganoderma lucidum on low-density lipoprotein oxidation and monocyte adhesion to endothelium]
Zhang HM, Yao WJ, Tian HK.
Zhongguo Zhong Xi Yi Jie He Za Zhi. 2002 Jul;22(7):534-7.

Mechanisms of hypoglycemic activity of ganoderan B: a glycan of Ganoderma lucidum fruit bodies.
Hikino H, Ishiyama M, Suzuki Y, Konno C.
Planta Med. 1989 Oct;55(5):423-8. 

Ganoderic acid and its derivatives as cholesterol synthesis inhibitors.
Komoda Y, Shimizu M, Sonoda Y, Sato Y.
Chem Pharm Bull (Tokyo). 1989 Feb;37(2):531-3.

[Anti-atherosclerotic properties of higher mushrooms (a clinico-experimental investigation)]
Li Khva Ren, Vasil'ev AV, Orekhov AN, Tertov VV, Tutel'ian VA.
Vopr Pitan. 1989 Jan-Feb;(1):16-9.

Isolation and structure determination of a cholesterol esterase inhibitor from Ganoderma lucidum.
Kim SD.
J Microbiol Biotechnol. 2010 Nov;20(11):1521-3.